Novo Integrated Sciences Inc
NASDAQ:NVOS
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Novo Integrated Sciences Inc
NASDAQ:NVOS
|
64.8k USD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
97.3B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
65.2B EUR |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
74.6B USD |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
29.3B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
24.2B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.3B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.2B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.9B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Novo Integrated Sciences Inc
Glance View
Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 113 full-time employees. The company went IPO on 2005-07-12. The company owns Canadian and United States subsidiaries, which provide solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutics, personalized product offerings, and rehabilitative science. Its Canadian subsidiary, Novo Healthnet Limited, provides its services and products through both clinic and eldercare related operations. The company has two segments: healthcare services, and product manufacturing and development. Its primary care services include physiotherapy, chiropractic care, occupational therapy, eldercare, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury, kinesiology, vestibular therapy, and others. The company also provides global consulting specialized in providing value-added services for pharmaceutical, biotech, healthcare, hospital, medical, others.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Novo Integrated Sciences Inc is 43.2%, which is below its 3-year median of 84.9%.
Over the last 3 years, Novo Integrated Sciences Inc’s Gross Margin has increased from 41% to 43.2%. During this period, it reached a low of 26.1% on May 31, 2022 and a high of 350.9% on May 31, 2023.
